Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Come on news.
nice action this afternoon. Lets see .003 by Friday. Go ARCS!!!
there she goes again but going the wrong direction.
Everyone sleeping?
Don't see anything happening.
Does someone know something? Shares bought after closing.
Arcis Resources Corporation announces launch of Desigual hemp infused energy drinks for 1st quarter of 2016
1 hour ago - ACQUIREMEDIA
WEST PALM BEACH, Fla., Dec. 16, 2015 /PRNewswire/ -- Arcis Resources Corporation (OTC Pink: ARCS) announces launch of Desigual hemp infused energy drinks for 1st quarter of 2016. The energy drinks will contain hemp infused seed oil. Fatty acids in hemp oil are associated with health benefits that include protection against heart disease, cancer, bowel disease and other auto immune diseases. Hemp has been cultivated for thousands of years; moreover, widely used in food and other commercial and industrial products. In addition, Arcis Resources Corporation is now trading as ARCS. Furthermore, upgraded to pink current on the OTC Markets.
About Arcis Resources Corporation by and through its wholly owned subsidiaries is a technology solution provider with strong focus on software, web, mobile apps, and social media. We specialize in developing online information and directory portals for markets that strategically bring revenue, and growth. Our goal is to serve as a platform for software, web, mobile app, and social media development used for licensing, and distribution worldwide.
Safe Harbor Statement
This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control. Some of these factors include the ability of the company to raise sufficient capital, attract qualified management, attract new customers and effectively compete against similar companies.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/arcis-resources-corporation-announces-launch-of-desigual-hemp-infused-energy-drinks-for-1st-quarter-of-2016-300193881.html
SOURCE Arcis Resources Corporation
$1.55 now with 848 volume
754 in volume not showing up again here.
Finished at $1.80
back to $1.20
.8 now. come on thought it would stay over the $1
Let's hope so. And sooner will be better.
Let's see a nice jump in the am
ya my RBC account shows 888 in volume sitting at $1.40
I use Scotiabank they said tomorrow my shares will be in my account.
Let's have a green Monday and stay above $3.
look like a little bit of a red day. Hope next week will pass $5 again.
what will happen with this stock move up, stay here or move down?
bid at .25 what lol
10K out now
when ihub have this ticker ready I cant see it on my watchlist
Q-10 is out
Sounds good to me
Sitting at 2.50 right now.
4.50 now over 2000 volume
Ihub little slow today. It's at 3.01 with over 1800 volume.
How is this split going to work tomorrow?
Gapper this morning maybe
Thanks Skiluc let's have a great week next week.
my RBC is still only showing 1.22
Wake me up when this starts to trade!!
will trade at all today? Still seeing no action
UPDATE - Rx Safes Announces Patent Acquisition
13 minutes ago - ACQUIREMEDIA
HENDERSON, NV -- (Marketwired) -- 11/12/15 -- Rx Safes, Inc. (OTC PINK: RXSFD), the developer of patented autonomous fingerprint healthcare security products announced today that it has acquired another patent that further expands the company's intellectual property portfolio, protecting its Rx SafeDOSE, Patient Controlled Analgesia pendant.
The patent inventor, Phillip Jurson, MD., a nationally renowned anesthesiologist and pain management physician, was awarded patent number 7,806,852 -- method and apparatus for patient-controlled medical therapeutics utilizing biometrics in a patient controlled administration of pain medications, with a priority date in April 2006. This patent strengthens the company's intellectual property surrounding its Rx SafeDOSE product. The patent also includes claims that cover additional control features on the pendant, which will provide an even greater level of safety for patients and allow Rx Safes the ability to corner the market for the secure patient administration of medications.
"In developing this patent, it was my intention to solve the critical problem of PCA by Proxy," indicated patent inventor, Phillip Jurson, M.D. "I am extremely encouraged that through my relationship with Rx Safes, this issue can finally be addressed in a practical manner," added Dr. Jurson.
"We are putting infusion pump manufacturers such as Hospira, Baxter, Abbott and Smiths Medical on notice that we have already developed and proven the next generation of universal PCA pendant controllers, to provide improved security and patient safety when used in conjunction with each of their respective infusion pumps in a PCA setting," commented Lorraine Yarde, CEO of Rx Safes, Inc.
There are in excess of 600,000 PCA Pendants in use in hospitals throughout the US alone, and this does not consider usage in the home or in assisted living/nursing facilities. These devices have a short operating lifespan and are typically replaced every 10 to 14 months. "This is a multi-billion dollar market and what makes our position even stronger is that we have a product ready for FDA approval that is protected by two extremely valuable patents. There have been no improvements to infusion pump pendants in decades and we view this as a key entry point because the Rx SafeDOSE uses fingerprint technology to authenticate an authorized user before medication is administered. In order for the leading pump manufacturers to utilize this technology they will be forced to look to us for the solution and we are ready and willing to open discussions," Ms. Yarde added.
The company continues to build the value of its patent portfolio in the area of medical devices incorporating our fingerprint technology. Through developing and acquiring product specific intellectual property, we strengthen our ability to protect our innovative products from competition as we continue to establish Rx Safes™ as the trusted brand in biometric products for healthcare.
The One World Doll Project Founder to Address Shareholder Questions in CEOLIVE.TV Interview
2 minutes ago - ACQUIREMEDIA
HOUSTON--(BUSINESS WIRE)--Oct. 20, 2015-- The One World Doll Project, a subsidiary of One World Holdings, Inc. (OTCQB: OWOO), announced today that it has released a recent interview with its Founder, Trent T. Daniel, in which he lays out the company’s 2016 growth plan and responds to shareholder questions.
"One of the most important things we want our shareholders to know is that their questions are important to us and that we are listening," stated Mr. Daniel. "While it isn’t possible to address every inquiry from shareholders, it is my intent to use this interview to have a straight to the point, real talk discussion about this company and where we are headed in the near future," he added.
The video can be viewed on the company website at oneworlddolls.com/investors and at CEOLIVE.TV.
New tweet
$RXSF - Today marks our first retail sales program. Months of planning. Stocked and ready to deliver with new pharmacy partner - CVS Health.
Amazon Best Sellers Rank: #4,811 in Health & Personal Care (See Top 100 in Health & Personal Care)
#12 in Health & Personal Care > Sports Nutrition > Endurance & Energy > Drinks
now you search it on Amazon and it actually comes up at the first product. Not like before you had to search many pages before you found it.
Rx Safes Announces New Product Rights Acquisition
1 hour ago - ACQUIREMEDIA
HENDERSON, NV -- (Marketwired) -- 10/06/15 -- Rx Safes, Inc. (OTC PINK: RXSF), the developer of autonomous fingerprint healthcare security products designed to combat drug abuse and diversion, announced today that it has formed a partnership with MIKA MEDICAL and MK GLOBAL, a leading Korean innovative medical device and distribution company, to exclusively distribute their proprietary, reusable needleless injection system in the US market. The agreement calls for Rx Safes to further develop the product by integrating its autonomous fingerprint interface into the device, allowing only authorized patients and healthcare workers the ability to administer controlled substances including serious pain medications, through painless injection. Rx Safes will own all of the new intellectual property rights developed as part of this initiative and MIKA, which is an ISO:13485 certified manufacturer, will manufacture the new fingerprint activated needleless device for Rx Safes.
"The MyDOSE product is a reusable needleless injection system that will feature the company's autonomous fingerprint technology, so only authorized patients and caregivers can inject medication for pain, once authenticated by the device. This is another innovative application of our company's technology into an existing medical device, and is consistent with our company mission to secure the storage and dispensing of potentially dangerous medications," noted Lorraine Yarde, CEO at Rx Safes, Inc.
The Injectable Drug Delivery Market exceeds $326 billion presently and is expected to grow to $574 billion by 2020. Through this new partnership, Rx Safes will be developing the world's first fingerprint activated needleless injection system, and will be well positioned to capture its share of this growing market. Needleless injection systems have been slowly gaining traction and the FDA has approved certification of these devices in the areas of flu vaccinations and insulin administration because they are designed to deliver medications efficiently and pain-free, without breaking or puncturing the skin. "There is a real need to ensure individuals are actually authorized to inject controlled medications as part of a pain management program whether recuperating from surgery or otherwise treating withdrawals from addiction," noted Rx Safes' Board Member, Dr. Susan Kutzner. "The company believes that this product will revolutionize pain free administration of controlled medications and will be adopted quickly by the healthcare community," Dr. Kutzner added.
To date the FDA has required needleless injection systems be paired with a pharmaceutical formulary in order to be awarded FDA 510K certification. The company has started discussions with a high profile pharmaceutical company that concentrates on manufacturing pain medications. The company expects to file for certification with the FDA for this product once that relationship is finalized, possibly as soon as early next quarter.
Time to fly to silver.